Author:
Singh Vishwajeet,Singh Mukul Kumar,Kumar Anil,Sahu Dinesh Kumar,Jain Mayank,Pandey Anuj Kumar,Mantasha ,Singh Shubhendu,Verma Ajay Kumar
Funder
Indian Council of Medical Research
University Grants Commission - South Eastern Regional Office
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Perlis N, Krahn M, Alibhai S, Finelli A, Ritvo P, Bremner K, et al. Mp15–01 developing the bladder utility symptom scale: a multiattribute health state classification for bladder cancer. J Urol. 2014;4:191(4S).
2. Ciocan C, Pira E, Coggiola M, Franco N, Godono A, La Vecchia C, et al. Mortality in the cohort of talc miners and millers from Val Chisone, Northern Italy: 74 years of follow-up. Environ Res. 2022;203: 111865.
3. Boustead GB, Fowler S, Swamy R, Kocklebergh R, Hounsome L. Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry. BJU Int. 2014;113(6):924–30.
4. Teoh JY-C, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Recurrence mechanisms of non-muscle-invasive bladder cancer—a clinical perspective. Nat Rev Urol 2022;19(5):280‒94.
5. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, et al. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75–94.